THE USE OF BRUM1 RESEQUENCING MICROARRAY TO IDENTIFY MUTATIONS IN PATIENTS WITH NEONATAL CHOLESTASIS
J.G. Hartley, Paul Gissen(Great Ormond Street Hospital), CJ Hendriksz, R. M. Brown, David P. McMullen(Johns Hopkins University), Ute Baumann(The University of Adelaide), A. S. Knisely(Medical University of Graz), F MacDonald, Ekkehard Sturm(University Children's Hospital Tübingen), Bjarne Udd(Folkhälsans Forskningscentrum), Kirsten McKay, E. P. Maher
UCL Discovery (University College London)
October 1, 2010
Cited by 0
Related Papers
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
|Nature Medicine|2011|333
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326